At a glance
- Originator Merck & Co
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 07 Jun 2001 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 19 Jan 1995 Preclinical development for HIV-1 infections in USA (Unknown route)